Join our Community
Support ToI and remove all ads
Learn more
English
العربية
Français
فارسی
עברית
Get The Daily Edition
Account
Sign In
search
search
Home
Israel & the Region
Jewish Times
Israel Inside
The Blogs
Startup Israel
Newsletters
The Daily Edition
What Matters Most Today
Startup Daily
Updates from Silicon Wadi
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Battling COVID
Weekly Update
Partners
Atlanta
Atlanta Jewish Times
New York
The Jewish Week
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Get the Daily Edition
submit
Follow us
Facebook
Twitter
© 2020 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
search
Gilead Sciences Inc.
November 20, 2020, 1:44 pm
WHO advises against using drug remdesivir for treating COVID patients
UN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has ‘no important effect’ on improving survival chances
By
Patrick Galey
October 23, 2020, 6:46 am
FDA approves first COVID-19 drug: antiviral remdesivir
Medicine found to cut recovery time by five days on average, but no studies have shown it improves chances of surviving the coronavirus
By
MARILYNN MARCHIONE
June 16, 2020, 8:05 pm
Israel to accept COVID-19 drug remdesivir from US company
Government backs Health Ministry in authorizing Gilead Sciences’ donation of medicine
By
TOI staff
and
Agencies
June 1, 2020, 8:24 pm
Gilead stock drops amid mixed results on drug remdesivir’s effects on virus
Company-led study finds those who who got medication for 5 days improved 65%, while there was no proven difference when getting it for 10 days; more details to be published
By
AP
and
TOI staff
May 23, 2020, 5:01 pm
Big study casts more doubt on malaria drugs pushed by Trump as virus treatment
Researchers estimate death rate slightly higher among those taking hydroxychloroquine; separate study on remdesivir suggests benefit in treating COVID-19
By
AP
and
TOI staff
May 9, 2020, 4:24 am
Israeli firm uncovers Iran-linked attempt to hack US virus drugmaker Gilead
Pharmaceutical company is pioneering treatment for coronavirus; ClearSky cybersecurity outfit says Iran-connected hackers are targeting COVID-19 researchers, including in Israel
By
TOI staff
May 4, 2020, 1:31 pm
Remdesivir results for virus encouraging but too early to celebrate — local CEO
FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear
By
TOI staff
and
AP
May 2, 2020, 4:47 pm
New US test could detect virus before patients become infectious
Defense Department working on new blood-based screening that identifies body’s immune response, may find illness 4 days earlier than current swab tests
By
TOI staff
and
AP
May 2, 2020, 12:58 am
Trump announces emergency approval for 1st drug shown to help virus recovery
In preliminary US trial, Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with ‘severe disease’
By
MATTHEW PERRONE
and
MARILYNN MARCHIONE
April 29, 2020, 7:35 pm
Experimental drug declared by US as first effective treatment against COVID-19
Dr. Anthony Fauci says trial on patients shows GIlead Sciences remdesivir ‘can block this virus,’ American government to work to boost availability of the antiviral medication
By
Martin Crutsinger
,
MARILYNN MARCHIONE
and
Anne D'Innocenzio
March 30, 2020, 8:37 pm
Bus driver who was Israel’s first serious virus patient makes full recovery
Johnny, from East Jerusalem, drove a group of Greek tourists later found to be carrying coronavirus; was treated with Remdesivir, which was originally developed for Ebola
By
TOI staff
From the Web
December 10, 2017, 2:07 pm
Gilead Sciences acquires CDL for $567m
Globes: Cell Design Labs (CDL) is developing cancer therapies based on CAR T, likely to be the next generation of medications
October 19, 2017, 3:49 pm
Israeli-founded Kite Pharma gets FDA nod for cancer therapy
Firm started by Israeli-US oncologist Arie Belldegrun was acquired by US firm Gilead Sciences for almost $12 billion in August
By
Shoshanna Solomon
August 30, 2017, 4:20 pm
Breakthrough Israeli cancer professor on prowl to ease other ills
Weizmann Institute’s Zelig Eshhar’s genetically engineered T-cells are at the heart of Kite Pharma’s $12 billion acquisition
By
Shoshanna Solomon
August 28, 2017, 6:55 pm
Gilead to buy Israeli-founded Kite Pharma for nearly $12 billion
The US firm, founded in 2009 by Israeli-US oncologist Arie Belldegrun, develops cell therapies for cancer treatments
By
Shoshanna Solomon
Load More